• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Caesarstone Reports Fourth Quarter and Full Year 2024 Financial Results

    3/5/25 7:00:00 AM ET
    $CSTE
    Building Materials
    Industrials
    Get the next $CSTE alert in real time by email

    - Fourth Quarter Revenue of $97.9 Million and Full Year Revenue of $443.2 Million -

    - Full Year Gross Margin Improved 550 Basis Points to 21.8% -

    - Full Year Cash Flow from Operations of $31.9 Million -

    - Strong Balance Sheet with Net Cash Position of $101.8 Million -

    Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its fourth quarter and full year ended December 31, 2024.

    Yos Shiran, Caesarstone's Chief Executive Officer commented, "Caesarstone delivered resilient adjusted EBITDA performance for the full year, even as our revenue reflects the persistent global market headwinds affecting our industry. Throughout 2024, we made meaningful progress on our transformation strategy, focusing on strengthening our R&D capabilities, expanding our zero crystalline silica and porcelain product offerings globally, and optimizing our operational framework. The operational enhancements implemented across our business have significantly improved our cash flow generation and working capital efficiency, while positioning us to achieve substantially higher profitability as revenues recover. We have successfully executed upon our strategic restructuring plan exemplified by our improved gross margin. While market conditions remain challenging, we are confident that our strategic initiatives and disciplined execution have created a more agile and efficient organization ready to capitalize on market opportunities in 2025."

    Fourth Quarter 2024 Results

    Revenue in the fourth quarter of 2024 was $97.9 million compared to $128.5 million in the prior year quarter. On a constant currency basis, fourth quarter revenue was down 23.8% year-over-year primarily due to lower volumes. Volumes were primarily impacted by global economic headwinds across the Company's main regions resulting in lower demand accompanied by greater competitive pressures.

    Gross margin in the fourth quarter of 2024 improved to 19.4% compared to 18.1% in the prior year quarter. Adjusted gross margin in the fourth quarter improved to 19.7%, compared to 18.9% in the prior year quarter. The improvement in gross margin was mainly due to the benefits of an improved production footprint, partially offset by unfavorable product mix and lower production, which resulted in lower fixed costs absorption.

    Operating expenses in the fourth quarter of 2024 were $41.9 million, or 42.9% of revenue, compared to $56.5 million, or 43.9% of revenue in the prior year quarter. During the quarter, the Company recorded a $7.8 million non-cash pre-tax impairment and restructuring charges related to intangible assets and the Sdot Yam and Richmond Hill manufacturing facility closures. Excluding legal settlements and loss contingencies, restructuring and impairment expenses, operating expenses were 33.3% of revenue compared to 24.3% in the prior year quarter, primarily due to lower revenues.

    Operating loss in the fourth quarter of 2024 was $23.0 million compared to $33.2 million in the prior year quarter, with the difference primarily reflecting lower impairment charges recorded partially offset by lower gross profit.

    Adjusted EBITDA in the fourth quarter of 2024, which excludes expenses for non-cash share-based compensation, legal settlements and loss contingencies, impairment and restructuring charges and other non-recurring items, was a loss of $8.0 million, compared to a gain of $1.4 million in the prior year quarter.

    Finance (income) expenses in the fourth quarter of 2024 was $2.9 million compared to $3.7 million in the prior year quarter. The difference primarily reflects foreign currency exchange rate fluctuations.

    Net loss attributable to controlling interest for the fourth quarter of 2024 was $24.3 million compared to a net loss of $50.5 million in the prior year quarter. Net loss per share for the fourth quarter was $0.60 compared to a net loss per share of $1.47 in the prior year quarter. Adjusted diluted net loss per share for the fourth quarter was $0.35 on 34.7 million shares, compared to Adjusted diluted net loss per share of $0.28 in the prior year quarter on 34.5 million shares.

    Full Year 2024 Results

    Revenue in the full year 2024 was $443.2 million compared to $565.2 million in the prior year. On a constant currency basis, 2024 revenue was lower by 21.5% year-over-year, primarily due to lower volume.

    Gross margin in 2024 improved to 21.8% compared to 16.3% in the prior year. Adjusted gross margin in 2024 was 22.1% compared to 17.0% in the prior year. The improvement in gross margin was primarily attributable to the benefits of an improved production footprint, partially offset by unfavorable product mix and lower production, which resulted in lower fixed cost absorption.

    Operating expenses in 2024 were $138.6 million compared to $180.0 million in the prior year. During 2024, the Company recorded a $1.0 million restructuring and impairment charge related to intangible assets and to the Sdot Yam and Richmond Hill manufacturing facility closures. Excluding legal settlements, loss contingencies, impairment and restructuring charges, adjusted operating expenses were 29.4% of revenue, compared to 24.2% in the prior year, with the difference primarily attributable to lower revenues.

    Operating loss in 2024 was $41.9 million compared to an operating loss of $88.0 million in the prior year. The year-over-year difference mainly reflects lower restructuring and impairment expenses recorded during 2024.

    Adjusted EBITDA, which excludes non-cash impairment and restructuring charges, expenses for share-based compensation, legal settlements and loss contingencies and non-recurring items, was a loss of $11.5 million in 2024 compared to a loss of $9.4 million in the prior year.

    Finance (income) expense in 2024 was breakeven compared to finance income of $1.1 million in the prior year. The difference was primarily a result of foreign currency exchange rate fluctuations.

    Net loss attributable to controlling interest in 2024 was $42.8 million compared to net loss of $107.7 million in the prior year. Net loss per share for 2024 was $1.13 compared to a diluted net loss per share of $3.13 in the prior year. Adjusted diluted net loss per share for 2024 was $0.86 on 34.7 million shares compared to adjusted diluted net loss per share of $1.34 in the prior year on 34.6 million shares.

    Balance Sheet & Liquidity

    As of December 31, 2024, the Company's balance sheet included cash, cash equivalents and short-term bank deposits of $106.3 million and total debt to financial institutions of $4.5 million. The Company's net cash position as of December 31, 2024, was $101.8 million compared to $83.5 million as of December 31, 2023.

    US Legal Proceedings Update

    As of December 31, 2024, the Company was subject to lawsuits with respect to 296 injured persons alleging injuries associated with exposure of fabricators and their employees to respirable crystalline silica dust. Of these, 52 were in Israel, 122 in Australia and 122 in the United States. In the U.S. Company was subject to an adverse jury decision in August 2024 which it is appealing and it settled another claim recently. As of December 31, 2024, the Company has recorded a provision of $50.0 million representing its assessment of exposure that is probable and estimable with respect to pending claims in Israel, the United States and Australia. As of December 31, 2024, the Company's insurance receivables for silicosis-related claims totaled $32.2 million. The Company has assessed the remaining 120 claims in the U.S. and determined that a loss is only reasonably possible or that the claims are still in an early stage. As a result, no accrual has been recorded in its financial results as of December 31, 2024.

    If there is a change in the assessment for the outcome of the claims or the insurance coverage through the course of the trial processes, such changes could lead to a material and adverse impact on our business, financial position, results of operations or cash flows.

    For more information, please reference the full disclosure provided in the Company's 2024 annual report on Form 20-F.

    Outlook

    "Looking ahead, while market conditions remain dynamic, we expect to see modest improvement in full year 2025 adjusted EBITDA compared to full year 2024 as we realize the full benefits of our cost optimization initiatives and strategic investments. We remain focused on the disciplined execution of our transformation while continuing to invest strategically in innovation and marketing to drive long-term profitable growth," concluded Nahum Trost, Caesarstone's Chief Financial Officer.

    Webcast and Conference Call Details

    The Company will host a webcast and conference call today, March 5, 2025, at 8:30 a.m. ET to discuss the results, followed by a question and answer session for the investment community. The live webcast can be accessed through the Investor Relations section of the Company's website at ir.caesarstone.com. For those unable to access the webcast, the conference call will be accessible domestically or internationally, by dialing 1-833-816-1463 and 1-412-542-4167, respectively. The toll-free Israeli number is 1 80 921 3284. Upon dialing in, please request to join the Caesarstone Fourth Quarter 2024 Earnings Conference Call.

    To listen to a telephonic replay of the conference call, dial toll-free 1-844-512-2921 or +1-412-317-6671 (international) and enter pass code 10196433. The replay will be available beginning at 12:30 p.m. ET on Wednesday, March 5, 2025 and will last through 11:59 p.m. ET on Wednesday, March 12, 2025.

    About Caesarstone

    Caesarstone is a global leader of premium surfaces, specializing in countertops that create dynamic spaces of inspiration in the heart of the home. Established in 1987, its multi-material portfolio of over 100 colors combines the company's innovative technology with its powerful design passion. Spearheading high-quality, sustainable surfaces, Caesarstone delivers functional resilience with timeless beauty, for a vast range of applications, including kitchen countertops, bathroom vanities, and more, for indoor and outdoor spaces.

    Since it pioneered quartz countertops over thirty years ago, the brand has expanded into porcelain and natural stone and is on the ground in more than 50 countries worldwide while enhancing customer experience through the expansion of groundbreaking digital platforms & services. More information on Caesarstone: caesarstoneus.com, Facebook, LinkedIn and Instagram

    The Company has filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. securities and exchange commission ("SEC") and can be accessed on its website.

    Non-GAAP Financial Measures

    The non-GAAP measures presented by the Company should be considered in addition to, and not as a substitute for, comparable GAAP measures. Reconciliations of GAAP gross profit to Adjusted gross profit, GAAP net income (loss) to Adjusted net income (loss) and net income (loss) to Adjusted EBITDA are provided in the schedules to this release. To calculate revenues growth rates that exclude the impact of changes in foreign currency exchange rates, the Company converts actual reported results from local currency to U.S. dollars using constant foreign currency exchange rates in the current and comparable period. The Company provides these non-GAAP financial measures because it believes that they present a better measure of the Company's core business and management uses the non-GAAP measures internally to evaluate the Company's ongoing performance. Accordingly, the Company believes that they are useful to investors in enhancing an understanding of the Company's operating performance.

    Forward-Looking Statements

    Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "goals," "intend," "seek," "anticipate," "believe," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements regarding the Company's goals and plans, intentions, expectations, assumptions, goals and beliefs regarding the Company's business. Actual results may differ materially from those projections and estimates due to various risks and uncertainties, both known or unknown. These factors include, but are not limited to: the effects of global and regional economy and geo-politics on the Company's business and operations including the length, duration and impact of the war in Israel, the Houthi's disruption to the movement of goods in the Red Sea and trade disruptions such as Turkey's decision not to trade with Israel; the outcome of silicosis and other bodily injury claims, and the availability relevant insurance; regulatory changes and requirements relating to the manufacturing and fabrication of our products; the outcome of our restructuring efforts, of the closure of the Sdot Yam and Richmond Hill Facilities, the estimated closure costs and the estimated potential savings relating to said closures, the ability to sell or sublease all or part of these facilities; our ability to effectively collaborate with production business partners; our R&D and product introduction efforts, managing constraints in the global supply chain and effectively procuring raw materials and goods as well as fluctuations in their price; our ability to protect our brand, technology and intellectual property, as well as our freedom to operate; competitive pressures; disruptions to our information technology systems, fluctuations in currency exchange rates against the U.S. dollar; our ability to successfully integrate our acquisitions; our ability to meet ESG goals and targets; and other risks and uncertainties discussed under the sections "Risk Factors" and "Special Note Regarding Forward-Looking Statements and Risk Factor Summary" in our most recent annual report on Form 20-F filed with the Securities and Exchange Commission (the "SEC") on March 6, 2024, and in other documents filed by Caesarstone with the SEC, which are available free of charge at www.sec.gov. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

    Caesarstone Ltd. and its subsidiaries

    Condensed consolidated balance sheets

     
    As of
    U.S. dollars in thousands December 31, 2024 December 31, 2023
    (Unaudited) (Audited)
    ASSETS
     
    CURRENT ASSETS:
     
    Cash and cash equivalents and short-term bank deposits

    $

    106,336

    $

    91,123

    Trade receivables, net

     

    46,880

     

    66,888

    Other accounts receivable and prepaid expenses (*)

     

    82,651

     

    25,489

    Inventories

     

    112,609

     

    136,446

     
    Total current assets

     

    348,476

     

    319,946

     
    LONG-TERM ASSETS:
     
    Severance pay fund

     

    1,526

     

    1,994

    Deferred tax assets, net

     

    2,910

     

    3,061

    Long-term deposits and prepaid expenses

     

    4,750

     

    4,961

    Operating lease right-of-use assets

     

    115,392

     

    120,156

    Property, plant and equipment, net (*)

     

    75,724

     

    123,480

    Intangible assets, net

     

    263

     

    6,257

     
    Total long-term assets

     

    200,565

     

    259,909

     
    Total assets

    $

    549,041

    $

    579,855

     
    LIABILITIES AND EQUITY
     
    CURRENT LIABILITIES:
     
    Short-term bank credit

    $

    4,555

    $

    5,118

    Trade payables

     

    52,838

     

    42,848

    Related parties

     

    206

     

    257

    Short term legal settlements and loss contingencies

     

    42,706

     

    16,106

    Accrued expenses and other liabilities

     

    51,383

     

    56,894

     
    Total current liabilities

     

    151,688

     

    121,223

     
    LONG-TERM LIABILITIES:
     
    Long-term bank and other loans

     

    444

     

    2,549

    Legal settlements and loss contingencies long-term and other liabilities

     

    9,492

     

    11,814

    Deferred tax liabilities, net

     

    2,439

     

    3,006

    Long-term lease liabilities

     

    107,313

     

    114,146

    Accrued severance pay

     

    2,978

     

    3,065

    Long-term warranty provision

     

    902

     

    1,204

     
    Total long-term liabilities

     

    123,568

     

    135,784

     
    REDEEMABLE NON-CONTROLLING INTEREST

     

    2,200

     

    7,789

     
    EQUITY:
     
    Ordinary shares

     

    371

     

    371

    Treasury shares - at cost

     

    (39,430)

     

    (39,430)

    Additional paid-in capital

     

    166,500

     

    164,456

    Capital fund related to non-controlling interest

     

    (5,587)

     

    (5,587)

    Accumulated other comprehensive income (loss), net

     

    (14,870)

     

    (8,402)

    Retained earnings

     

    164,601

     

    203,651

     
    Total equity

     

    271,585

     

    315,059

     
    Total liabilities and equity

    $

    549,041

    $

    579,855

     
    (*) During the first half of 2024, we reclassified approximately $41.3M from fixed assets to held for sale assets in accordance with ASC360.
    Caesarstone Ltd. and its subsidiaries

    Condensed consolidated statements of income (loss)
     

    Three months ended December 31,

     

    Twelve months December 31,

    U.S. dollars in thousands (except per share data)

    2024

     

    2023

     

    2024

     

    2023

    (Unaudited)

     

    (Unaudited)

     
    Revenues

    $

    97,863

    $

    128,525

    $

    443,221

    $

    565,231

    Cost of revenues

     

    78,875

     

    105,245

     

    346,546

     

    473,292

     
    Gross profit

     

    18,988

     

    23,280

     

    96,675

     

    91,939

     
    Operating expenses:
    Research and development

     

    1,446

     

    1,249

     

    4,950

     

    5,086

    Sales and Marketing

     

    20,191

     

    19,764

     

    86,239

     

    82,222

    General and administrative

     

    10,915

     

    10,168

     

    39,123

     

    49,490

    Restructuring and Impairment expenses related to long lived assets (*)

     

    7,763

     

    27,715

     

    1,007

     

    47,939

    Legal settlements and loss contingencies, net

     

    1,629

     

    (2,424)

     

    7,242

     

    (4,770)

     
    Total operating expenses

     

    41,944

     

    56,472

     

    138,561

     

    179,967

     
    Operating loss

     

    (22,956)

     

    (33,192)

     

    (41,886)

     

    (88,028)

    Finance loss (income), net

     

    2,860

     

    3,747

     

    9

     

    (1,069)

     
    Loss before taxes

     

    (25,816)

     

    (36,939)

     

    (41,895)

     

    (86,959)

    Tax expenses (income), net

     

    (1,361)

     

    13,949

     

    1,081

     

    21,281

     
    Net loss

    $

    (24,455)

    $

    (50,888)

    $

    (42,976)

    $

    (108,240)

     
    Net loss attributable to non-controlling interest

     

    111

     

    367

     

    144

     

    584

     
    Net loss attributable to controlling interest

    $

    (24,344)

    $

    (50,521)

    $

    (42,832)

    $

    (107,656)

    Basic net loss per ordinary share (**)

    $

    (0.60)

    $

    (1.47)

    $

    (1.13)

    $

    (3.13)

    Diluted net loss per ordinary share (**)

    $

    (0.60)

    $

    (1.47)

    $

    (1.13)

    $

    (3.13)

    Weighted average number of ordinary shares used in computing basic loss per ordinary share

     

    34,547,633

     

    34,522,015

     

    34,539,378

     

    34,519,126

    Weighted average number of ordinary shares used in computing diluted loss per ordinary share

     

    34,547,633

     

    34,522,015

     

    34,539,378

     

    34,519,126

     
     
    (*) Including long-lived assets impairment and restructuring expenses related to plants closure. Also includes capital gain related to sale of undeveloped land and certain equipment in the Richmond Hill plant.
    (**) The numerator for the calculation of net loss per share for the three and twelve months ended December 31, 2024 and 2023, has been increased (decreased) by approximately $3.8 and $3.8 million and ($0.1) and ($0.5) million, respectively, to reflect the adjustment to redemption value associated with the redeemable non-controlling interest.
    Caesarstone Ltd. and its subsidiaries

    Selected Condensed consolidated statements of cash flows

     

    Twelve months December 31,

    U.S. dollars in thousands

    2024

     

    2023

    (Unaudited)

     

    (Unaudited)

    Cash flows from operating activities:
     
    Net loss

    $

    (42,976)

    $

    (108,240)

    Adjustments required to reconcile net loss to net cash provided by operating activities:
    Depreciation and amortization

     

    17,134

     

    30,007

    Share-based compensation expense

     

    2,043

     

    1,025

    Accrued severance pay, net

     

    392

     

    (268)

    Changes in deferred tax, net

     

    (621)

     

    11,905

    Capital loss

     

    980

     

    18

    Legal settlements and loss contingencies, net

     

    7,242

     

    (4,771)

    Decrease in trade receivables

     

    18,748

     

    11,760

    Decrease in other accounts receivable and prepaid expenses

     

    6,858

     

    8,145

    Decrease in inventories

     

    20,128

     

    101,549

    Increase (decrease) in trade payables

     

    8,952

     

    (29,464)

    Decrease in warranty provision

     

    (579)

     

    (165)

    Changes in right of use assets

     

    3,371

     

    7,865

    Changes in lease liabilities

     

    (5,006)

     

    (9,516)

    Amortization of premium and accretion of discount on marketable securities, net

     

    -

     

    63

    Changes in Accrued interest related to Marketable Securities

     

    -

     

    39

    Decrease in accrued expenses and other liabilities including related parties

     

    (5,799)

     

    (1,362)

    Restructuring expenses and Impairment related to long lived assets

     

    1,007

     

    47,939

    Net cash provided by operating activities

     

    31,874

     

    66,529

     
     
    Cash flows from investing activities:
     
    Net cash paid for acquisitions

     

    (1,556)

     

    -

    Purchase of property, plant and equipment

     

    (10,421)

     

    (11,168)

    Proceeds from sale of property, plant and equipment

     

    67

     

    177

    Maturity of marketable securities

     

    -

     

    7,100

    Decrease (increase) in long term deposits

     

    51

     

    (135)

     
    Net cash used in investing activities

     

    (11,859)

     

    (4,026)

     
     
    Cash flows from financing activities:
     
    Changes in short-term bank credits and long-term loans, including related parties

     

    (2,545)

     

    (23,268)

    Contingent consideration related to acquisition

     

    (500)

     

    (511)

     
    Net cash used in financing activities

     

    (3,045)

     

    (23,779)

     
     
    Effect of exchange rate differences on cash and cash equivalents

     

    (1,757)

     

    318

     
    Increase (decrease) in cash and cash equivalents and short-term bank deposits

     

    15,213

     

    39,042

    Cash and cash equivalents and short-term bank deposits at beginning of the period

     

    91,123

     

    52,081

     
    Cash and cash equivalents and short-term bank deposits at end of the period

    $

    106,336

    $

    91,123

     
    Non - cash investing:
    Changes in trade payables balances related to purchase of fixed assets

     

    106

     

    188

    Caesarstone Ltd. and its subsidiaries
     

    Three months ended December 31,

     

    Twelve months December 31,

    U.S. dollars in thousands

    2024

     

    2023

     

    2024

     

    2023

    (Unaudited)

     

    (Unaudited)

    Reconciliation of Gross profit to Adjusted Gross profit:
    Gross profit

    $

    18,988

    $

    23,280

    $

    96,675

    $

    91,939

    Share-based compensation expense (a)

     

    11

     

    (59)

     

    89

     

    94

    Amortization of assets related to acquisitions

     

    70

     

    71

     

    282

     

    286

    Residual operating expenses (income) related to closed plants after closing

     

    96

     

    1,129

     

    672

     

    3,924

    Other non recurring items

     

    141

     

    (152)

     

    182

     

    (304)

    Adjusted Gross profit (Non-GAAP)

    $

    19,306

    $

    24,269

    $

    97,900

    $

    95,939

     

    (a)

    Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.

    Caesarstone Ltd. and its subsidiaries
     

    Three months ended December 31,

     

    Twelve months December 31,

    U.S. dollars in thousands

    2024

     

    2023

     

    2024

     

    2023

    (Unaudited)

     

    (Unaudited)

    Reconciliation of Net Loss to Adjusted EBITDA:
    Net loss

    $

    (24,455)

    $

    (50,888)

    $

    (42,976)

    $

    (108,240)

    Finance loss (income), net

     

    2,860

     

    3,747

     

    9

     

    (1,069)

    Taxes on income

     

    (1,361)

     

    13,949

     

    1,081

     

    21,281

    Depreciation and amortization

     

    4,363

     

    7,296

     

    17,742

     

    30,007

    Legal settlements and loss contingencies, net (a)

     

    1,629

     

    (2,425)

     

    7,242

     

    (4,771)

    Contingent consideration adjustment related to acquisition

     

    -

     

    24

     

    (53)

     

    264

    Share-based compensation expense (b)

     

    434

     

    469

     

    2,044

     

    1,025

    Restructuring expenses (income) and Impairment related to long lived assets (c)

     

    7,827

     

    27,715

     

    1,005

     

    47,939

    Residual operating expenses related to closed plants after closing

     

    450

     

    1,643

     

    2,056

     

    4,438

    Other non recurring items

     

    284

     

    (152)

     

    325

     

    (304)

    Adjusted EBITDA (Non-GAAP)

    $

    (7,969)

    $

    1,378

    $

    (11,525)

    $

    (9,430)

     
     

    (a)

    Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims.

    (b)

    Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.

    (c)

    Including long-lived assets impairment and restructuring expenses related to plants closure. Also includes capital gain related to sale of undeveloped land and certain equipment in the Richmond Hill plant.

    Caesarstone Ltd. and its subsidiaries
     

    Three months ended December 31,

     

    Twelve months December 31,

    U.S. dollars in thousands (except per share data)

    2024

     

    2023

     

    2024

     

    2023

    (Unaudited)

     

    (Unaudited)

    Reconciliation of net loss attributable to controlling interest to adjusted net loss attributable to controlling interest:
    Net loss attributable to controlling interest

    $

    (24,344)

    $

    (50,521)

    $

    (42,832)

    $

    (107,656)

    Legal settlements and loss contingencies, net (a)

     

    1,629

     

    (2,425)

     

    7,242

     

    (4,771)

    Contingent consideration adjustment related to acquisition

     

    -

     

    24

     

    (53)

     

    264

    Amortization of assets related to acquisitions, net of tax

     

    532

     

    534

     

    2,135

     

    2,142

    Share-based compensation expense (b)

     

    434

     

    469

     

    2,044

     

    1,025

    Non cash revaluation of lease liabilities (c)

     

    977

     

    3,538

     

    (2,039)

     

    (1,556)

    Restructuring expenses (income) and Impairment related to long lived assets (d)

     

    7,827

     

    27,715

     

    1,005

     

    47,939.00

    Residual operating expenses related to closed plants after closing

     

    450

     

    1,643

     

    2,056

     

    4,438

    Other non recurring items

     

    284

     

    (152)

     

    325

     

    (304)

    Total adjustments

     

    12,133

     

    31,346

     

    12,715

     

    49,177

    Less tax on non-tax adjustments (e)

     

    (240)

     

    (9,421)

     

    (328)

     

    (12,035)

    Total adjustments after tax

     

    12,372

     

    40,767

     

    13,043

     

    61,212

     
    Adjusted net loss attributable to controlling interest (Non-GAAP)

    $

    (11,972)

    $

    (9,754)

    $

    (29,789)

    $

    (46,444)

    Adjusted loss per share (f)

    $

    (0.35)

    $

    (0.28)

    $

    (0.86)

    $

    (1.34)

     
     

    (a)

    Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims.

    (b)

    Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.

    (c)

    Exchange rate differences deriving from revaluation of lease contracts in accordance with FASB ASC 842.

    (d)

    Including long-lived assets impairment and restructuring expenses related to plants closure. Also includes capital gain related to sale of undeveloped land and certain equipment in the Richmond Hill plant.

    (e)

    Tax adjustments for the three and twelve months ended December 31, 2024 and 2023, based on the effective tax rates.

    (f)

    In calculating adjusted (Non-GAAP) loss per share, the diluted weighted average number of shares outstanding excludes the effects of share-based compensation expense in accordance with FASB ASC 718.

    Caesarstone Ltd. and its subsidiaries
    Geographic breakdown of revenues by region
     

    Three months ended December 31,

     

    Twelve months December 31,

    Three months ended December 31, Twelve months December 31,
    U.S. dollars in thousands

    2024

     

    2023

     

    2024

     

    2023

    (Unaudited) (Unaudited) (Audited)

    YoY % change

     

    YoY % change CCB

     

    YoY % change

     

    YoY % change CCB

     
    USA

    $

    46,353

    $

    60,286

    $

    219,559

    $

    271,647

    -23.1%

    -23.1%

    -19.2%

    -19.2%

    Canada

     

    14,106

     

    17,750

     

    61,749

     

    75,462

    -20.5%

    -18.5%

    -18.2%

    -17.0%

    Latin America

     

    244

     

    817

     

    1,392

     

    3,285

    -70.1%

    -70.4%

    -57.6%

    -57.7%

    America's

     

    60,703

     

    78,853

     

    282,700

     

    350,394

    -23.0%

    -22.6%

    -19.3%

    -19.1%

     
    Australia

     

    16,870

     

    26,684

     

    75,388

     

    106,223

    -36.8%

    -37.5%

    -29.0%

    -28.8%

    Asia

     

    4,317

     

    5,890

     

    20,577

     

    25,959

    -26.7%

    -26.8%

    -20.7%

    -21.1%

    APAC

     

    21,187

     

    32,574

     

    95,965

     

    132,182

    -35.0%

    -35.5%

    -27.4%

    -27.2%

     
    EMEA

     

    11,858

     

    14,513

     

    47,121

     

    59,908

    -18.3%

    -18.2%

    -21.3%

    -22.1%

     
    Israel

     

    4,115

     

    2,585

     

    17,435

     

    22,747

    59.2%

    53.6%

    -23.4%

    -23.0%

     
    Total Revenues

    $

    97,863

    $

    128,525

    $

    443,221

    $

    565,231

    -23.9%

    -23.8%

    -21.6%

    -21.5%

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250305044642/en/

    Investor Relations:

    ICR, Inc. - Rodny Nacier

    [email protected]

    +1 (646) 200-8870

    Get the next $CSTE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CSTE

    DatePrice TargetRatingAnalyst
    3/6/2025Buy → Speculative Buy
    The Benchmark Company
    More analyst ratings

    $CSTE
    SEC Filings

    See more
    • SEC Form 6-K filed by Caesarstone Ltd.

      6-K - Caesarstone Ltd. (0001504379) (Filer)

      5/7/25 4:30:08 PM ET
      $CSTE
      Building Materials
      Industrials
    • SEC Form 20-F filed by Caesarstone Ltd.

      20-F - Caesarstone Ltd. (0001504379) (Filer)

      3/5/25 4:20:32 PM ET
      $CSTE
      Building Materials
      Industrials
    • SEC Form 6-K filed by Caesarstone Ltd.

      6-K - Caesarstone Ltd. (0001504379) (Filer)

      11/13/24 7:31:26 AM ET
      $CSTE
      Building Materials
      Industrials

    $CSTE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Caesarstone Reports First Quarter 2025 Financial Results

      - Revenue of $99.6 Million - - Gross Margin of 21.3% - - Strong Balance Sheet with Net Cash Position of $85.3 Million - - Continued Progress on Strategic Transformation and Cost Optimization Initiatives - Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its first quarter ended March 31, 2025. Yos Shiran, Caesarstone's Chief Executive Officer commented, "We delivered modest sequential improvement this quarter as our business continues to stabilize in a challenging market environment. These results reflect our ability to effectively navigate a complex global landscape while advancing key initiat

      5/7/25 7:00:00 AM ET
      $CSTE
      Building Materials
      Industrials
    • Caesarstone Announces Date for First Quarter 2025 Results

      Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today announced that it will release its earnings results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 before the market opens. The Company will host a webcast and conference call on the same day at 8:30 a.m. ET to discuss the results, followed by a question and answer session for the investment community. The live webcast can be accessed through the Investor Relations section of the Company's website at ir.caesarstone.com. For those unable to access the webcast, the conference call will be accessible domestically or internationally, by dialing 1-833-816-1463 an

      4/23/25 4:15:00 PM ET
      $CSTE
      Building Materials
      Industrials
    • Caesarstone Reports Fourth Quarter and Full Year 2024 Financial Results

      - Fourth Quarter Revenue of $97.9 Million and Full Year Revenue of $443.2 Million - - Full Year Gross Margin Improved 550 Basis Points to 21.8% - - Full Year Cash Flow from Operations of $31.9 Million - - Strong Balance Sheet with Net Cash Position of $101.8 Million - Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its fourth quarter and full year ended December 31, 2024. Yos Shiran, Caesarstone's Chief Executive Officer commented, "Caesarstone delivered resilient adjusted EBITDA performance for the full year, even as our revenue reflects the persistent global market headwinds affecting our i

      3/5/25 7:00:00 AM ET
      $CSTE
      Building Materials
      Industrials

    $CSTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Caesarstone Ltd.

      SC 13G/A - Caesarstone Ltd. (0001504379) (Subject)

      11/14/24 6:21:59 AM ET
      $CSTE
      Building Materials
      Industrials
    • SEC Form SC 13G/A filed by Caesarstone Ltd. (Amendment)

      SC 13G/A - Caesarstone Ltd. (0001504379) (Subject)

      2/26/24 9:14:46 AM ET
      $CSTE
      Building Materials
      Industrials
    • SEC Form SC 13G/A filed by Caesarstone Ltd. (Amendment)

      SC 13G/A - Caesarstone Ltd. (0001504379) (Subject)

      2/8/24 3:18:47 PM ET
      $CSTE
      Building Materials
      Industrials

    $CSTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Caesarstone downgraded by The Benchmark Company

      The Benchmark Company downgraded Caesarstone from Buy to Speculative Buy

      3/6/25 7:23:44 AM ET
      $CSTE
      Building Materials
      Industrials
    • Stifel resumed coverage on Caesarstone with a new price target

      Stifel resumed coverage of Caesarstone with a rating of Hold and set a new price target of $18.00

      5/28/21 6:47:03 AM ET
      $CSTE
      Building Materials
      Industrials

    $CSTE
    Financials

    Live finance-specific insights

    See more
    • Caesarstone Reports First Quarter 2025 Financial Results

      - Revenue of $99.6 Million - - Gross Margin of 21.3% - - Strong Balance Sheet with Net Cash Position of $85.3 Million - - Continued Progress on Strategic Transformation and Cost Optimization Initiatives - Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its first quarter ended March 31, 2025. Yos Shiran, Caesarstone's Chief Executive Officer commented, "We delivered modest sequential improvement this quarter as our business continues to stabilize in a challenging market environment. These results reflect our ability to effectively navigate a complex global landscape while advancing key initiat

      5/7/25 7:00:00 AM ET
      $CSTE
      Building Materials
      Industrials
    • Caesarstone Announces Date for First Quarter 2025 Results

      Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today announced that it will release its earnings results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 before the market opens. The Company will host a webcast and conference call on the same day at 8:30 a.m. ET to discuss the results, followed by a question and answer session for the investment community. The live webcast can be accessed through the Investor Relations section of the Company's website at ir.caesarstone.com. For those unable to access the webcast, the conference call will be accessible domestically or internationally, by dialing 1-833-816-1463 an

      4/23/25 4:15:00 PM ET
      $CSTE
      Building Materials
      Industrials
    • Caesarstone Reports Fourth Quarter and Full Year 2024 Financial Results

      - Fourth Quarter Revenue of $97.9 Million and Full Year Revenue of $443.2 Million - - Full Year Gross Margin Improved 550 Basis Points to 21.8% - - Full Year Cash Flow from Operations of $31.9 Million - - Strong Balance Sheet with Net Cash Position of $101.8 Million - Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its fourth quarter and full year ended December 31, 2024. Yos Shiran, Caesarstone's Chief Executive Officer commented, "Caesarstone delivered resilient adjusted EBITDA performance for the full year, even as our revenue reflects the persistent global market headwinds affecting our i

      3/5/25 7:00:00 AM ET
      $CSTE
      Building Materials
      Industrials

    $CSTE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

      Announcement reflects company's commitment to augment Board of Directors with industry-experienced executives from both the government and software sectors Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in investigative analytics software, today announced the appointment of two new members to its Board of Directors. Matthew O'Neill and Nurit Benjamini will join the board on March 1, 2025, and March 31, 2025, respectively, reflecting the company's commitment to add independent directors from the government and software sectors. Richard Nottenburg will be stepping down from his board position effective March 31, 2025. Having served with the United States Secret Service f

      2/18/25 8:00:00 AM ET
      $ALLT
      $BLRX
      $CGEN
      $CGNT
      Computer Communications Equipment
      Telecommunications
      Biotechnology: Pharmaceutical Preparations
      Health Care